| 2024-03-27 | +1.85 % |
|
| 2024-03-26 | -0.83 % |
- The article discusses how Kingswood Wealth Advisors LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 372.5% in the 4th quarter, with several other institutional investors also adding to their stakes. However, the Thermo Fisher Scientific (TMO) stock went down by -0.83%, possibly due to insiders, including SVP Michael A. Boxer and CEO Marc N. Casper, selling significant amounts of company stock.
- The article discusses shareholding changes in Thermo Fisher Scientific Inc. (NYSE:TMO), with Windward Capital Management Co. CA reducing their stake, while other institutions increased their positions; however, the stock went down -0.83% last night likely due to recent insider selling and adjustments in institutional holdings.
- The article discusses Howard Capital Management Group LLC increasing its position in Thermo Fisher Scientific Inc., stating that its stock was down by -0.83%. The stock likely went down due to a combination of factors, such as market conditions, investor sentiment, recent financial results, and potentially profit-taking by institutional investors.
|
| 2024-03-25 | -1.63 % |
- The article discusses CFRA's rating upgrade of Thermo Fisher Scientific (TMO) from Hold to Buy, with a new price target of $635 and an elevated EPS projection for the year 2025, which reflects confidence in the company's growth prospects; overall, the stock may have gone down due to a downward revision of the EPS estimate for 2024, particularly in the first quarter.
- The summary of the article is that Thermo Fisher Scientific Inc. (TMO) stock was down by -1.63% last night, and the stock decreased due to various institutional investors lessening their holdings in the company, recent insider stock sales, and a drop in quarterly revenue for the medical research company.
- Summary: Cooper Financial Group acquired a new position in Thermo Fisher Scientific Inc. (TMO) in the fourth quarter, while other large investors also modified their holdings, leading to a -1.63% stock decrease, potentially influenced by recent insider selling activities and institutional investor changes.
Reason for TMO stock decline: The decrease in TMO stock might be attributed to recent insider selling activities by company directors and the changes in positions by institutional investors such as Cooper Financial Group acquiring a stake in the company.
|
| 2024-03-22 | -0.18 % |
|
| 2024-03-21 | +0.7 % |
|
| 2024-03-20 | -0.46 % |
|
| 2024-03-19 | +0.46 % |
|
| 2024-03-18 | -0.7 % |
|
| 2024-03-15 | -0.13 % |
|
| 2024-03-14 | -1.42 % |
|
| 2024-03-13 | -0.66 % |
- Summary: The article announces Achyuta Rajaram as the winner of the Regeneron Science Talent Search 2024, highlighting the achievements of young innovators in STEM fields.
Reason for Thermo Fisher Scientific (TMO) stock going down: Due to the nature of the information provided in the article not being directly related to Thermo Fisher Scientific and its stock, it is difficult to pinpoint a specific reason for the stock going down. However, stock prices can fluctuate based on various factors such as market conditions, company performance, economic indicators, and investor sentiment.
- The article discusses Thermo Fisher Scientific's (NYSE:TMO) stock performance, focusing on its Return on Equity (ROE) and growth prospects. Thermo Fisher Scientific's stock went down last night, likely due to the market reacting to the company's performance and growth potential, as indicated by the ROE and earnings growth analysis presented in the article.
- The article provides an overview of Eurofins' Environmental, Social, and Governance (ESG) achievements and progress in its latest report, including highlights such as reductions in carbon intensity, participation in renewable energy projects, and recognition for diversity. Thermo Fisher Scientific (TMO) stock went down due to a collaboration mentioned in the report, indicating that Eurofins signed a deal with Thermo Fisher Scientific for a stake in the Serbal Solar Project, impacting TMO's energy consumption positively while potentially causing a short-term negative market reaction.
|
| 2024-03-11 | +0.3 % |
|
| 2024-03-07 | +1.04 % |
- The article discusses Banzai International, Inc.'s expansion of its event marketing solution, Reach, aimed at enhancing customer support and addressing market demand, with companies like Thermo Fisher Scientific using Reach for event marketing strategies; however, it also highlights Banzai's financial challenges with negative P/E ratio and revenue decline, suggesting caution for potential investors despite the recent stock price fluctuations.
- The article discusses the increase in Thermo Fisher Scientific (TMO) stock, up 1.04% last night, driven by the tech sector surge, including smaller tech players, with the company's Relative Strength Rating improving from 69 to 73 due to a 42% increase in its stock since late October.
|
| 2024-03-01 | +1.08 % |
|
| 2024-02-29 | -0.32 % |
|
| 2024-02-28 | +1.04 % |
- The article discusses the biotech industry and provides insights into investing in biotech stocks, highlighting both the potential benefits - such as significant returns driven by groundbreaking discoveries and advancements in healthcare, as well as drawbacks - like regulatory hurdles, clinical trial failures, and market volatility. Thermo Fisher Scientific (TMO) stock went up by 1.04% following the news that it provides a test capable of detecting the new omicron variant, positioned as the sole FDA-authorized test with this capability, which likely contributed to the stock's increase.
- Operose Advisors LLC significantly increased its stake in Thermo Fisher Scientific, leading to a rise in the stock price, and various other hedge funds have also recently adjusted their holdings contributing to its increase, indicating strong investor interest and positive analyst ratings.
- Summary: Connor Clark & Lunn Investment Management Ltd. bought a new position in Thermo Fisher Scientific Inc., with several other hedge funds and institutional investors also purchasing shares of the stock, leading to a 1.04% increase in its value; the company's stock went up due to positive investor sentiment from institutional purchases and strong financial performance reflected in their quarterly earnings report, which exceeded analysts' expectations.
Reason for Stock Increase: Thermo Fisher Scientific's stock went up due to positive investor sentiment resulting from institutional purchases and the company's strong financial performance, as seen in its quarterly earnings report that exceeded analysts' expectations.
|
| 2024-02-27 | +0.48 % |
|
| 2024-02-23 | +0.75 % |
|
| 2024-02-21 | +0.86 % |
|
| 2024-02-15 | +0.05 % |
- Thermo Fisher Scientific (TMO) stock was up 0.05% recently, and the stock has received a "Moderate Buy" recommendation from fifteen research firms, with four analysts rating the stock as a hold and eleven as a buy; the average price target for the stock is $596. The stock may have gone up due to positive ratings and recommendations from analysts, as well as the recent announcement of a $4 billion stock buyback plan.
- The article announces that Banzai International, Inc., a marketing technology company, has had its registration statement declared effective by the Securities and Exchange Commission (SEC), bringing the company closer to accessing capital through a Standby Equity Purchase Agreement. The article does not provide a specific reason for why Thermo Fisher Scientific's stock went up.
- The article announces the appointment of Agnes Lee as Senior Vice President of Investor Relations and Corporate Communications at ACELYRIN, INC., a clinical biopharma company, and does not provide information on why Thermo Fisher Scientific (TMO) stock went up by 0.05%.
|
| 2024-02-13 | -1.51 % |
|
| 2024-02-08 | -0.26 % |
|
| 2024-02-07 | -1.42 % |
|
| 2024-02-06 | +1.57 % |
|
| 2024-02-05 | -0.04 % |
|
| 2024-02-02 | -0.07 % |
|
| 2024-01-31 | -4.96 % |
|
| 2024-01-30 | +1.68 % |
|
| 2024-01-29 | +1.91 % |
|
| 2024-01-26 | +1.69 % |
|
| 2024-01-25 | -0.33 % |
|
| 2024-01-24 | -1.95 % |
|
| 2024-01-19 | +1.35 % |
|
| 2024-01-11 | +0.38 % |
|
| 2024-01-08 | +1.91 % |
- The article discusses the success and net worth of Casper, a leading company in the bedding industry, and also mentions the stock trades of Marc N. Casper, the CEO of Thermo Fisher Scientific. The stock of Thermo Fisher Scientific went up by 1.91%, but the article does not provide a specific reason for this increase.
- Shares of Thermo Fisher Scientific (TMO) went up 1.91% as the company announced an agreement with Akoya Biosciences, provided its 2024 outlook, and gave preliminary fourth-quarter expectations, with Akoya Biosciences expecting revenue growth and cash flow breakeven.
- The article is not about Thermo Fisher Scientific (TMO) stock going up, but rather about Bitfarms Ltd., a Bitcoin mining company, appointing Tracy Krumme as Senior Vice President, Head of Investor Relations; therefore, it does not provide an explanation for why TMO stock went up.
|
| 2024-01-05 | -1.14 % |
|
| 2024-01-04 | +1.61 % |
|
| 2024-01-02 | +2.52 % |
|
| 2023-12-21 | +1.37 % |
|
| 2023-12-15 | -0.67 % |
- The article announces the closing of a business combination between 7GC & Co. Holdings and Banzai International, resulting in the formation of a new company called Banzai International, Inc., which will begin trading on the Nasdaq. The article does not provide specific information on why Thermo Fisher Scientific (TMO) stock went down.
- The article states that Benny Buller has stepped down as the Chief Executive Officer of Velo3D, a metal additive manufacturing technology company, and Brad Kreger has been appointed as the interim CEO while the company searches for a permanent CEO. The announcement of the leadership change has triggered a strategic business review process to explore options such as a strategic transaction, potential merger, business combination, or sale, in an effort to maximize shareholder value. The article does not provide any information about the impact of this news on Thermo Fisher Scientific (TMO) stock.
- The article is not about Thermo Fisher Scientific stock (TMO) going down; instead, it discusses the closing of a business combination between 7GC & Co. Holdings Inc. and Banzai International, Inc. The combination resulted in the creation of Banzai International, Inc., which will commence trading its Class A common stock on the Nasdaq Global Market. Therefore, the article does not provide a reason for Thermo Fisher Scientific stock going down.
|
| 2023-12-12 | +0.48 % |
- Madryn Asset Management, an institutional investor in SomaLogic, has filed a preliminary proxy statement opposing the proposed merger between SomaLogic and Standard BioTools, citing a low valuation of SomaLogic and conflicts of interest in the deal, and urges shareholders to vote against the merger at the upcoming Special Meeting on January 4, 2024; Madryn believes SomaLogic has better alternatives, including leveraging its cash position and strong balance sheet or pursuing a standalone path.
- Orthofix Medical has appointed three new independent directors to its board with the aim of advancing the company's position as a global spine and orthopedics company, in partnership with one of its largest shareholders, Engine Capital Management. The new directors bring substantial experience in finance, strategic development, healthcare and medical technology, which is expected to drive enhanced shareholder value and contribute to profitable growth for Orthofix.
|
| 2023-12-11 | +1.07 % |
|
| 2023-12-07 | +0.06 % |
|
| 2023-12-06 | +0.45 % |
|
| 2023-11-29 | +1.44 % |
|
| 2023-11-28 | -0.86 % |
|
| 2023-11-21 | +2.85 % |
|
| 2023-11-20 | +0.56 % |
|
| 2023-11-15 | +2.46 % |
|
| 2023-11-14 | +3.17 % |
|
| 2023-11-13 | -0.73 % |
|
| 2023-11-09 | -2.21 % |
|
| 2023-11-07 | +0.93 % |
|
| 2023-11-03 | +1.6 % |
|
| 2023-11-02 | +1.46 % |
|
| 2023-10-31 | +2.46 % |
|
| 2023-10-30 | +0.63 % |
|
| 2023-10-27 | -1.99 % |
|
| 2023-10-26 | +1.61 % |
|
| 2023-10-25 | -5.47 % |
|
| 2023-10-24 | -0.77 % |
|
| 2023-10-20 | -1.13 % |
|
| 2023-10-19 | +0.52 % |
|
| 2023-10-18 | -3.61 % |
|
| 2023-10-17 | -0.77 % |
|
| 2023-10-16 | +1.18 % |
|
| 2023-10-13 | +0.06 % |
|
| 2023-10-10 | |
|
| 2023-10-09 | -0.49 % |
|
| 2023-10-05 | -0.88 % |
|
| 2023-10-03 | +0.77 % |
|